OncoSil Medical Limited / Fundamentals
Income statement
- Net revenue
€926.15K - Cost of goods sold
€7.65M - Gross profit
-€7.02M - SG&A expenses
€6.30M - R&D expenses
€3.07M - EBITDA
-€14.37M - D&A
€101.88K - EBIT
-€14.52M - Interest expenses
€5.24K - EBT
-€14.78M - Tax expenses
-€1.17M - Net income
-€13.88M
Cash flow statement
- Net deferred tax
€36.79K - Non-cash items
€445.90K - Changes in working capital
-€236.44K - Operating cash flow
-€12.80M - Capex
€147.28K - Other investing cash flow
€0.00 - Net investing cash flow
€5.11M - Total cash dividends paid
€0.00 - Issuance of common stock
€9.04M - Debt repayment
-€105.11K - Other financing cash flow
€14.57M - Net financing cash flow
€14.46M - Foreign exchange effects
-€5.26M - Net change in cash
€4.04M - Cash at end of period
€4.74M - Free cash flow
-€12.65M
Balance sheet
- Cash and cash equivalents
€4.74M - Cash and short-term investments
€4.74M - Total receivables
€228.32K - Inventory
€0.00 - Other current assets
€1.23M - Total current assets
€6.20M - Property, plant & equipment
€239.10K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€239.10K - Total assets
€6.44M - Accounts payable
€1.28M - Short-term debt
€18.66K - Other current liabilities
€328.02K - Total current liabilities
€1.63M - Long-term debt
€21.03K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€21.03K - Total liabilities
€1.65M - Common stock
€53.18M - Retained earnings
-€55.72M - Other equity
€7.34M - Total equity
€4.79M - Total liabilities and shareholders' equity
€6.44M
Company information
- Market capitalization
€9.24M - Employees
2 - Enterprise Value
€5.42M
Company ratios
- Gross margin
-
-758.3% Much worse than peer group: 319.2% - EBITDA margin
-
-1,551.1% Much better than peer group: -15,258.1% - EBIT margin
-
-1,568.0% Much better than peer group: -18,090.2% - EBT margin
-
-1,596.3% Much better than peer group: -3,115.3% - Net margin
-
-1,498.3% Much better than peer group: -4,108.9% - ROE
-
-289.4% Much worse than peer group: -136.6% - ROA
-
-215.4% Much worse than peer group: -115.3% - Asset turnover
-
14.4% Even with peer group: 16.7% - FCF margin
-
-1,397.9% Much worse than peer group: -802.5% - FCF yield
-140.1% - Efficiency ratio
1,651.1% - Net sales per employee
-
€463.08K - Net income per employee
-
-€6.94M